Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy

Trevor M. Feinstein, Stephen Y. Lai, Diana Lenzner, William Gooding, Robert L. Ferris, Jennifer R. Grandis, Eugene N. Myers, Jonas T. Johnson, Dwight E. Heron, Athanassios Argiris

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

Background This study was designed to identify the factors associated with the outcome after standard treatment with surgery and postoperative radiotherapy (RT) for locally advanced salivary gland cancers. Methods We conducted a retrospective review of patients with salivary gland cancers registered in the University of Pittsburgh databases from 1990 to 2006. Results A total of 74 patients were analyzed. Histologic types included salivary duct carcinoma, 24%; adenoid cystic carcinoma, 23%; and adenocarcinoma, 19%; N2, 39%; N0-1, 58%; and major salivary gland origin, 80%. With a median follow-up of 4.1 years, the 5-year recurrence-free survival (RFS) was 49%, and the 5-year overall survival (OS) was 55%. The 5-year local RFS was 76% and the 5-year distant RFS was 60%. Using Cox-regression analysis, advanced N classification (N2) was the only significant predictor of both RFS and OS. Conclusion The long-term survival of patients with high-risk, locally advanced salivary gland cancers is unsatisfactory. Advanced nodal disease is strongly associated with patient outcome and should be considered as a stratification factor in future trials in locally advanced salivary gland cancers.

Original languageEnglish (US)
Pages (from-to)318-323
Number of pages6
JournalHead and Neck
Volume33
Issue number3
DOIs
Publication statusPublished - Mar 1 2011

    Fingerprint

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Feinstein, T. M., Lai, S. Y., Lenzner, D., Gooding, W., Ferris, R. L., Grandis, J. R., ... Argiris, A. (2011). Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy. Head and Neck, 33(3), 318-323. https://doi.org/10.1002/hed.21444